神经科

订阅

MedSci主页 / 所有栏目 / 神经科

帕金森运动症状治疗的新方法：鞘内注射仙人掌毒素

2019-04-11 不详 网络

帕金森运动症状仙人掌毒素
关注

帕金森病（PD）是一种慢性神经退行性疾病，其特征在于运动症状，例如运动迟缓、静止性震颤、姿势紊乱和僵硬。许多临床和病理学研究表明，PD病变能够延伸到黑质以外，并且涉及非多巴胺能神经递质系统，其能够介导运动和非运动症状。Sorrento Therapeutics公司近日宣布，仙人掌毒素（Resiniferatoxin，RTX）能够控制PD的运动症状。

帕金森病（PD）是一种慢性神经退行性疾病，其特征在于运动症状，例如运动迟缓、静止性震颤、姿势紊乱和僵硬。许多临床和病理学研究表明，PD病变能够延伸到黑质以外，并且涉及非多巴胺能神经递质系统，其能够介导运动和非运动症状。Sorrento Therapeutics公司近日宣布，仙人掌毒素（Resiniferatoxin，RTX）能够控制PD的运动症状。

单次鞘内注射Resiniferatoxin对AAV-A53T诱导的PD样病理模型（C57Bl / 6J小鼠）的结果显示，在AAV-A53T后7天鞘内施用Resiniferatoxin能够显著改善精细运动功能，且Resiniferatoxin输注后小鼠没有明显的不良反应。然而，没有观察到纹状体中多巴胺及其代谢物水平的变化。


原始出处：

http://www.firstwordpharma.com/node/1634400#axzz5kmtmGZrh

本文系梅斯医学（MedSci）原创编译整理，转载需授权!

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-24 kord1982

    #新方法#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-12-01 ycmayy

    #仙人掌毒素#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-18 jin321

    厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-16 一个字-牛

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-13 坚强007

    向科研人员致敬！

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-13 sunrural_42825363

    #运动症状#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-13 zywlvao

    #鞘内注射#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1903362, encodeId=167819033620a, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Wed Apr 24 04:53:00 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036327, encodeId=493a203632e13, content=<a href='/topic/show?id=e8bc2536920' target=_blank style='color:#2F92EE;'>#仙人掌毒素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25369, encryptionId=e8bc2536920, topicName=仙人掌毒素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sun Dec 01 14:53:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364857, encodeId=30df36485ef0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Thu Apr 18 20:52:09 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364759, encodeId=4d69364e59a9, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Apr 16 20:14:25 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364596, encodeId=130136459617, content=向科研人员致敬！, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Sat Apr 13 16:39:23 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604815, encodeId=29451604815bb, content=<a href='/topic/show?id=950f9419633' target=_blank style='color:#2F92EE;'>#运动症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94196, encryptionId=950f9419633, topicName=运动症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33b19274468, createdName=sunrural_42825363, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615720, encodeId=d63c1615e2087, content=<a href='/topic/show?id=c75c9998e5d' target=_blank style='color:#2F92EE;'>#鞘内注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99987, encryptionId=c75c9998e5d, topicName=鞘内注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3bb19663119, createdName=zywlvao, createdTime=Sat Apr 13 11:53:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364499, encodeId=1cf636449953, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu Apr 11 21:11:46 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-11 329523732

    不错

    0

相关资讯

Nat Commun：肠道细菌如何影响帕金森病的治疗

发表在Nature Communications杂志上的研究，格罗宁根大学的科学家发现肠道细菌能将左旋多巴代谢成多巴胺。由于多巴胺不能穿过血脑屏障，这使得药物的疗效降低，即使存在会阻止左旋多巴转化为多巴胺的抑制剂。

第14届阿尔茨海默症和帕金森国际会议：Aptinyx将介绍NYX-458的临床前数据

Aptinyx是一家临床阶段的生物制药公司，开发用于治疗大脑和神经系统疾病的变革疗法，近日宣布即将在第14届阿尔茨海默症和帕金森国际会议上发表演讲，重点介绍其新型NMDA受体调节剂NYX-458的临床前数据

AGING CELL：心磷脂重塑联系线粒体功能障碍与帕金森病

心磷脂（CL）是线粒体特征性磷脂，其是膜结构，呼吸，动力学和线粒体自噬所必需的。活性氧对CL的氧化损伤与帕金森病（PD）的发病机制有关，但至今为止，其根本原因仍然难以捉摸。

从斑马鱼身上竟然获得治疗帕金森的方法！

与哺乳动物相比，成年斑马鱼会使大脑中的神经元再生，但这种能力的程度和变异性尚不清楚。来自Edinburgh大学脑神经科学研究中心的Thomas Becker及其研究团队探寻了各种多巴胺能神经元群体的丧失是否足以触发神经元的功能性再生。他们的研究结果为未来治疗具有运动异常、震颤等症状的神经系统疾病提供了新的思路。研究人员分析了斑马鱼两种性别的遗传谱系，其示踪显示特定的间脑室间室 - 放射状神经胶质祖

第14届阿尔茨海默症和帕金森国际会议：Eisai将公布其一系列在研药物的临床试验结果

Eisai公司近日宣布，将于3月26日举行的第14届阿尔茨海默症和帕金森国际会议上公布其一系列在研药物的临床试验结果：BAN2401，一种抗淀粉样蛋白β（Aβ）初原纤维抗体，正在进行III期试验；elenbecestat，一种口服选择性BACE1抑制剂，目前正在进行两项III期研究（MISSION AD1 / 2）。

实验性帕金森疗法显示出巨大前景

布里斯托大学的研究表明，一种新型实验药物很可能恢复帕金森病患者受损的脑细胞。